Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
Achieves 73 percent year-over-year revenue growth SAN FRANCISCO, July 19, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today reported financial results for the second quarter and six months ended June 30, 2016. Q2 2016 Highlights Revenue grew 73 percent to $8.2 million compared to revenue of $4.7 million in the 2015 second quarter. Gross margin expansion continued to 74.6 percent compared to 61.0 percent for the 2015 second quarter. Approximately 610 customers purchased Invuity devices in the second quarter of 2016, up from 445 customers in the second quarter of 2015. Approximately 186,000 procedures have been performed using ...Read More
SAN FRANCISCO, July 12, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that it will release its 2016 second quarter and six-month financial results after the market closes on Tuesday, July 19, 2016. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Tuesday, July 19, 2016, to discuss the financial results and other business developments. Interested parties may access the live call via telephone by dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 47469934. To listen to the live call via Invuit...Read More
SAN FRANCISCO, June 08, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that company management is scheduled to present at the William Blair 36th Annual Growth Stock Conference on Thursday, June 16, 2016, at 8:40 a.m. Central Time in Chicago. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation. About Invuity® Invuity, In...Read More
“I operate with greater efficiency and surgical precision because I can direct the light where I need it – the light follows me instead of me following the light. I have reduced my surgical time by an average of 15% and experience less operative blood loss. This challenging surgical approach is now easier, quicker and safer when using the Saber with Yankauer – it makes my life easier.”
Joint Replacement Surgery with Specialty in Anterior Approach Hip Replacement and Pelvic/Acetabular Trauma Surgery
Southeast Hospital and St. Francis Medical Center
Cape Girardeau, MO
“The Invuity Eika illuminated minimally invasive thyroid and parathyroid self-retracting technology has revolutionized our field of endocrine surgery. It allows for smaller incisions while improving surgical efficiency and safety. It provides superior visualization of vital structures, and has reduced operating times, improved patient outcomes, and decreased overall costs of the procedure. I would not do a case without this technology.”
Chief of Surgery, Mission Regional and Trauma Med Ctr.
Director, St. Joseph and Hoag Head & Neck Oncology & Endocrine Center
“Invuity has effectively married two critical technologies and addressed a pressing clinical need of visualization. The Saber Yankauer is one of the most significant technological advancements in orthopaedic surgery this year.”
Head of Orthopaedic Oncology
UAB Medical Center, Birmingham, AL